Dermata Therapeutics, Inc.
DRMA
$0.8721
-$0.0358-3.94%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 22.26% | -5.75% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.79% | 11.86% | |||
| Operating Income | 0.79% | -11.86% | |||
| Income Before Tax | 0.70% | -12.16% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 0.70% | -12.16% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.70% | -12.16% | |||
| EBIT | 0.79% | -11.86% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 55.08% | 51.19% | |||
| Normalized Basic EPS | 55.07% | 51.19% | |||
| EPS Diluted | 55.08% | 51.19% | |||
| Normalized Diluted EPS | 55.07% | 51.19% | |||
| Average Basic Shares Outstanding | 121.05% | 129.78% | |||
| Average Diluted Shares Outstanding | 121.05% | 129.78% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||